USPTO 2015–2025 USPTO PatentsView US Corporation

Chemrus, Inc.

USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (Chemical OR Physical Laboratory Apparatus FOR General USE).

RSS updates for this company

The verdict

According to USPTO PatentsView, Chemrus ranks #45,619 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.

#45,619
of 49,997 US assignees by volume
17th percentile
by Innovation Score (25.3/100)
9.0
avg claims per patent
-33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45619 · US Corporation #45,619 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,619/49,997
  • PHOTO-FINISH Chelak Medical…
  • CPC-NARROW B01L · 4 areas
  • INNOV-THIN 25.3/100
  • CLAIMS-PAR 9.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DOWN -33% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Chelak Medical Solutions Inc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Chemrus’s 25.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Chemrus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Chemrus's Innovation Score is 25.3/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Chemrus?

Each dot is one of Chemrus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Chemrus’s own 9.0 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Chemrus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 0102030 Granted patents (volume) Avg claims / patent Chelak Medical Solutions Inc - 5, 22.8Chelak Medical So…ChemLink Laboratories, LLC - 5, 18.8Chemlink Laborato…ChemStone, Inc. - 5, 16.6ChemstoneChembeau LLC - 5, 26ChembeauChengli Li - 5, 10.2Chengli LiChenope, Inc. - 5, 16.4ChenopeChentronics, LLC - 5, 14.6ChentronicsChiayo Electronics Co., Ltd. - 5, 2.2ChiayoChemrus, Inc. - 5, 9Chemrus
Chemrus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Chemrus's grants concentrate

Chemrus, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 60% of grants classified under B01L (Chemical OR Physical Laboratory Apparatus FOR General USE). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2015. By volume, Chemrus sits between Chelak Medical Solutions Inc and Chiayo Electronics Co., Ltd..

Chemrus's three-year grant acceleration

Chemrus, Inc. shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Chemrus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Chemrus holds 5 patents at rank #45,820, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Chemrus

By rank, the assignees closest to #45,820 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Chemrus's primary technology class.

Chemrus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2015201720212023 1
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Chemrus, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 20.0%
2017 2 40.0%
2021 1 20.0%
2023 1 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Chemrus, Inc.'s patent record in context - here's where to go next.

  • Chemrus, Inc.'s lead technology class is B01L (Chemical OR Physical Laboratory Apparatus FOR General USE), 60% of its portfolio - see every assignee active in that class. Explore B01L
  • Ranked #45,619 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Chemrus, Inc. against Chelak Medical Solutions Inc, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 25.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.